PROTAC BRD4 Degrader-37
PROTAC BRD4 Degrader-37 is a BRD4 PROTAC degrader with a DC50 of 36.4 nM. PROTAC BRD4 Degrader-37 recruits the E3 ubiquitin ligase TRIM21, binds to the PRYSPRY domain of TRIM21 (KD = 123 nM), and thereby mediates the ubiquitination and degradation of BRD4. PROTAC BRD4 Degrader-37 exhibits cytotoxicity against PANC-1 cells (GI50 = 0.282 μM). PROTAC BRD4 Degrader-37 can be used in studies related to pancreatic cancer.
(Pink: BRD4 ligand (HY-175242); Blue: TRIM21 E3 ligase ligand; Black: linker).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C46H55N3O6S2
- Masse moléculaire:810.08
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform PROTACs
More
Activité biologique
Description
IC50 & Target
[1]|
BRD4 36.4 nM (DC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PANC-1 | DC50 |
36.4 nM
|
BRD4 degradation in human PANC-1 cells measured via High-Content Analysis (HCA) assay after 24-hour treatment.
BRD4 degradation in human PANC-1 cells measured via High-Content Analysis (HCA) assay after 24-hour treatment.
|
40623734 |
| PANC-1 | GI50 |
0.282 μM
|
Antiproliferative activity against human PANC-1 cells assessed in an antiproliferation assay.
Antiproliferative activity against human PANC-1 cells assessed in an antiproliferation assay.
|
40623734 |
| PANC-1 | DC50 |
2.847 nM
|
BRD4 protein degradation in human PANC-1 cells assessed via High Content Analysis (HCA) assay following 24 h incubation.
BRD4 protein degradation in human PANC-1 cells assessed via High Content Analysis (HCA) assay following 24 h incubation.
|
40623734 |
In Vitro
PROTAC BRD4 Degrader-37 (TrimTAC-2) (0.01-1000000 nM; 24 h) dose-dependently degrades BRD4 in PANC-1 cells with a DC50 of 36.4 nM and a Dmax of 73% after 24-hour treatment, as measured by HCA assay[1].
PROTAC BRD4 Degrader-37 (TrimTAC-2) (0.001-100 μM) forms a dose-dependent ternary complex with 100 nM BRD4 and 100 nM His-TRIM21 in a cell-free FRET assay[1].
PROTAC BRD4 Degrader-37 (0.01-100000 nM; 24 h) (TrimTAC-2 / HGC-673) potently degrades BRD4 in PANC-1 cells with a DC50 of 2.847 nM and a maximum degradation of 73% after 24-hour treatment.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Masse moléculaire 810.08
-
Formule C46H55N3O6S2
-
SMILES
CSC1=CC=CC=C1C2=CC(S(C)(=O)=O)=C(C=C2)C(N(CC3CCCCC3)CCCCCCCNC(C4=CC5=C(C(C)=CC(C6=CN(C(C(C)=C6)=O)C)=C5)O4)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)